The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05020236
Brief Title: MagnetisMM-5: Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (MAGNETISMM-5)

First Submitted : August 11, 2021
First Submitted that Met QC Criteria : August 18, 2021
First Posted : August 25, 2021

Last Update Submitted that Met QC Criteria : March 8, 2024
Last Update Posted : March 12, 2024